Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive breast cancer registry launches to map Real-World patient outcomes

NCT ID NCT02819882

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is a registry that collects information from 1867 people with advanced breast cancer that cannot be removed by surgery or has spread. Researchers will track different breast cancer subtypes and patient characteristics to better understand the disease in real-world settings. No new treatment is being tested; the goal is to gather data for future research.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,867 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2016

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The target population for inclusion in this study is breast cancer patients recently diagnosed (from January 2016) with unresectable locally advanced or metastatic disease (either after a recurrence or as first diagnosis).

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients (males or females) diagnosed with unresectable locally advanced or MBC (either after a recurrence or as first diagnosis) from January 2016 onwards. 2. Patients who died are allowed to be included on the study. 3. Able and willing to provide written informed consent if they are alive. 4. Age ≥ 18 years. 5. Availability to medical records access and all data related to the disease management. Exclusion Criteria: None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast neoplasms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    39 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Althaia-Xarxa Assistencial de Manresa

    RECRUITING

    Manresa, Barcelona, 08243, Spain

  • Complejo Hospitalario Universitario A Coruña

    RECRUITING

    A Coruña, 15006, Spain

  • Complejo Hospitalario Universitario de Albacete

    RECRUITING

    Albacete, 02006, Spain

  • Complejo Hospitalario de Navarra

    RECRUITING

    Pamplona, Navarre, 31008, Spain

  • Consorci Sanitari de Terrassa

    RECRUITING

    Terrassa, Barcelona, 08227, Spain

  • Hosital General de Valencia

    RECRUITING

    Valencia, 46014, Spain

  • Hospital Clinic de Barcelona

    WITHDRAWN

    Barcelona, 08036, Spain

  • Hospital Clínico Lozano Blesa

    RECRUITING

    Zaragoza, 50009, Spain

  • Hospital Clínico Universitario Virgen de la Arrixaca

    RECRUITING

    Murcia, 30120, Spain

  • Hospital Clínico Universitario de Salamanca

    RECRUITING

    Salamanca, 37007, Spain

  • Hospital Clínico Universitario de Valencia

    RECRUITING

    Valencia, 46010, Spain

  • Hospital Dr. Negrín

    RECRUITING

    Las Palmas de Gran Canaria, Gran Canaria, 35010, Spain

  • Hospital General Universitario Gregorio Marañón

    RECRUITING

    Madrid, 28007, Spain

  • Hospital General de Elche

    RECRUITING

    Elche, Alicante, 03203, Spain

  • Hospital Infanta Sofía

    RECRUITING

    San Sebastián de los Reyes, Madrid, 28702, Spain

  • Hospital Lucus Augusti

    RECRUITING

    Lugo, 27003, Spain

  • Hospital Miguel Servet

    RECRUITING

    Zaragoza, 50009, Spain

  • Hospital Moisés Broggi_institut Catalá D´Oncologia

    RECRUITING

    Barcelona, 08970, Spain

  • Hospital Nuestra Señora de Sonsoles

    RECRUITING

    Ávila, 05004, Spain

  • Hospital San Juan de Alicante

    RECRUITING

    Alicante, 03550, Spain

  • Hospital Santa Creu i Sant Pau

    RECRUITING

    Barcelona, 08041, Spain

  • Hospital Son Llatzer

    RECRUITING

    Palma de Mallorca, Mallorca, 07198, Spain

  • Hospital Universitario Donostia

    RECRUITING

    San Sebastián, Donostia, 20014, Spain

  • Hospital Universitario Dr. Peset

    RECRUITING

    Valencia, 46017, Spain

  • Hospital Universitario Fundación Alcorcón

    RECRUITING

    Alcorcón, Madrid, 28922, Spain

  • Hospital Universitario Germans Trias i Pujol

    RECRUITING

    Barcelona, 08916, Spain

  • Hospital Universitario La Princesa

    RECRUITING

    Madrid, 28006, Spain

  • Hospital Universitario Reina Sofía

    RECRUITING

    Córdoba, 14004, Spain

  • Hospital Universitario Severo Ochoa

    RECRUITING

    Leganés, Madrid, 28911, Spain

  • Hospital Universitario Virgen del Rocío

    RECRUITING

    Seville, 41013, Spain

  • Hospital Universitario de Basurto

    RECRUITING

    Bilbao, Vizcaya, 48013, Spain

  • Hospital Universitario de Canarias

    RECRUITING

    Santa Cruz de Tenerife, Tenerife, 38320, Spain

  • Hospital Universitario de Fuenlabrada

    RECRUITING

    Fuenlabrada, Madrid, 28942, Spain

  • Hospital Universitario de Málaga

    RECRUITING

    Málaga, 29010, Spain

  • Hospital Virgen de la Salud

    RECRUITING

    Toledo, 45004, Spain

  • Hospital de León

    RECRUITING

    León, 24071, Spain

  • Hospital de Sagunto

    RECRUITING

    Sagunto, Valencia, 46520, Spain

  • Hospital del Mar

    RECRUITING

    Barcelona, 08003, Spain

  • ICO L´Hospitalet

    RECRUITING

    Barcelona, 08908, Spain

  • IVO-Instituto Valenciano de Oncología

    RECRUITING

    Valencia, 46009, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.